Ecolab stock posts Q3 growth, margin gains and 2027 target

Published on 11/13/2026 at 13:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ecolab stock benefits from faster organic growth and wider margins in the third quarter. Management sees a stronger path into 2027.

Growth and margin momentum

Global High-Tech organic sales rose 63% and Life Sciences organic sales increased 17% in the third quarter.
Ecolab expects adjusted diluted earnings per share of 8.10 to 8.20 US dollars for 2026.
Management expects fourth-quarter organic sales growth of 6% to 7% and an organic operating margin of about 20%.

Ecolab Inc., US2788651006, Illustration mit AI erstellt.

Ecolab's third-quarter performance accelerated across its core businesses and growth engines, according to the company's Ecolab investor release published on Tuesday, October 27. Reported sales rose 13% to 4.6948 billion US dollars in the quarter ended September 30, while organic sales increased 7%.

Ecolab stock traded at 277.95 euros on Lang & Schwarz at 17:30 CET on Thursday, November 12. The quote is a dated trading indication and is not paired with a verified Xetra closing comparison.

Growth engines lift profitability

Volume growth improved to 2% and pricing accelerated to 5%, helping Ecolab offset higher commodity costs. Reported operating income increased 7% to 810.5 million US dollars, while adjusted operating income advanced 14% to 893.4 million US dollars.

Organic operating income rose 11% to 872.1 million US dollars. The organic operating margin reached 19.6%, an increase of 70 basis points from the prior-year quarter. The company said pricing and productivity gains more than offset growth investments and higher input costs.

The strongest expansion came from Ecolab's growth platforms. Global High-Tech organic sales grew 63%, supported by water-circularity solutions for microelectronics and liquid-cooling technologies for AI data centers. Life Sciences organic sales increased 17% as the business gained share in bioprocessing, personal care and purification.

Acquisition costs remain a drag

Reported diluted earnings per share fell 5% to 1.95 US dollars, while adjusted diluted earnings per share rose 5% to 2.18 US dollars. Ecolab said the adjusted figure included an approximate 10% headwind from CoolIT acquisition-related amortization and financing costs. Net interest expense increased to 124.8 million US dollars from 55.3 million US dollars a year earlier, reflecting acquisition financing.

The distinction between reported and adjusted results remains important for investors. Organic operating performance improved, but acquisition integration, financing costs and special charges continue to weigh on reported profitability.

Management raises the 2027 bar

For 2026, Ecolab expects adjusted diluted earnings per share of 8.10 to 8.20 US dollars, representing growth of 8% to 9%. Fourth-quarter guidance calls for reported sales growth of 12% to 14%, organic sales growth of 6% to 7%, adjusted operating income margin of about 19% and organic operating income margin of about 20%.

Chief Executive Officer Christophe Beck said Ecolab expects 2027 organic sales growth at the upper end of its 5% to 7% target and adjusted operating margin to reach 20%. The company also expects the Ovivo Electronics and CoolIT acquisitions to contribute about two percentage points to annual organic sales growth one year after closing.

For shareholders, the central test is whether stronger pricing, productivity and high-growth businesses can offset the financing and integration burden from recent acquisitions. The next major focus is the company's mid-November investor update, where management is expected to provide more detail on its 2027 trajectory.

Broader developments for the S&P 500 may influence the trading environment for large US-listed companies.

More news and analyses on Ecolab stock